Integrated Diagnostics (IDHC) Competitors

Diaceutics (LON:DXRX) and Integrated Diagnostics (LON:IDHC) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, community ranking, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Do insiders & institutionals believe in DXRX or IDHC?

52.4% of Diaceutics shares are owned by institutional investors. Comparatively, 43.0% of Integrated Diagnostics shares are owned by institutional investors. 34.3% of Diaceutics shares are owned by company insiders. Comparatively, 34.0% of Integrated Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Do analysts prefer DXRX or IDHC?

Diaceutics presently has a consensus price target of GBX 160, suggesting a potential upside of 32.23%. Given Diaceutics' stronger consensus rating and higher possible upside, research analysts plainly believe Diaceutics is more favorable than Integrated Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Diaceutics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Integrated Diagnostics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more volatility and risk, DXRX or IDHC?

Diaceutics has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Integrated Diagnostics has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.

Does the media favor DXRX or IDHC?

In the previous week, Diaceutics had 1 more articles in the media than Integrated Diagnostics. MarketBeat recorded 1 mentions for Diaceutics and 0 mentions for Integrated Diagnostics. Diaceutics' average media sentiment score of 0.59 beat Integrated Diagnostics' score of 0.00 indicating that Diaceutics is being referred to more favorably in the media.

Company	Overall Sentiment
Diaceutics	Positive
Integrated Diagnostics	Neutral

Does the MarketBeat Community favor DXRX or IDHC?

Integrated Diagnostics received 41 more outperform votes than Diaceutics when rated by MarketBeat users. However, 88.24% of users gave Diaceutics an outperform vote while only 65.12% of users gave Integrated Diagnostics an outperform vote.

Company	Underperform	Outperform
Diaceutics	Outperform Votes 15 88.24%	Underperform Votes 2 11.76%
Integrated Diagnostics	Outperform Votes 56 65.12%	Underperform Votes 30 34.88%

Which has stronger valuation & earnings, DXRX or IDHC?

Integrated Diagnostics has higher revenue and earnings than Diaceutics. Diaceutics is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Diaceutics	£26.08M	3.92	-£2.84M	-£3.37	-35.89
Integrated Diagnostics	£23.29T	0.00	£4.01T	£0.03	12.04

Is DXRX or IDHC more profitable?

Integrated Diagnostics has a net margin of 17.21% compared to Diaceutics' net margin of -10.90%. Integrated Diagnostics' return on equity of 30.45% beat Diaceutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Diaceutics	-10.90%	-7.15%	-6.06%
Integrated Diagnostics	17.21%	30.45%	9.69%

Summary

Diaceutics and Integrated Diagnostics tied by winning 9 of the 18 factors compared between the two stocks.